{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:53:39Z","timestamp":1792007619048,"version":"4.4.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173449"],"award-info":[{"award-number":["82173449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Assessment of therapeutic response of psoriasis has relied traditionally on clinical observation, and effective non-invasive tools are desirable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To investigate the value of dermoscopy and high-frequency ultrasound (HFUS) in the monitoring of psoriatic lesions treated with biologics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with moderate-to-severe plaque psoriasis treated with biologics were evaluated by clinical, dermoscopic, and ultrasonic scores at weeks 0, 4, 8, and 12. Clinical scores, including Psoriasis Area Severity Index (PASI) and target lesion score (TLS), were evaluated at representative lesions. Dermoscopy was performed to assess the red background, vessels, and scales on a 4-point scale as well as the presence of hyperpigmentation, hemorrhagic spots, and linear vessels. HFUS was performed to measure the thicknesses of the superficial hyperechoic band and subepidermal hypoechoic band (SLEB). The correlation between clinical, dermoscopic, and ultrasonic evaluation was also analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 24 patients were analyzed and achieved 85.3 and 87.5% reduction of PASI and TLS, respectively, after 12 weeks of treatment. The red background, vessels, and scales scores under dermoscopy were reduced by 78.5, 84.1, and 86.5%, respectively. Some patients developed hyperpigmentation and linear vessels after treatment. Hemorrhagic dots slowly subside over the therapeutic course. Ultrasonic scores were significantly improved with an average reduction of 53.9% in superficial hyperechoic band thickness and 89.9% in SLEB thickness. TLS in the clinical variables, scales in dermoscopic variables, and SLEB in ultrasonic variables decreased the most significantly in the early stage of treatment (week 4) with 55.4, 57.7, and 59.1% (<jats:italic>P<\/jats:italic> &amp;gt; 0.05), respectively. Most of the variables, including the red background, vessels, scales, and SLEB thickness, were strongly correlated with TLS. High correlations were also found between the SLEB thickness and the red background or vessels scores, and between the superficial hyperechoic band thickness and the scales scores.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Both dermoscopy and HFUS were useful in the therapeutic monitoring of moderate-to-severe plaque psoriasis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1162873","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T07:36:02Z","timestamp":1687764962000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical, dermoscopic, and ultrasonic monitoring of the response to biologic treatment in patients with moderate-to-severe plaque psoriasis"],"prefix":"10.3389","volume":"10","author":[{"given":"Juncheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis prevalence in adults in the United States","volume":"157","author":"Armstrong","year":"2021","journal-title":"JAMA Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/jdv.16966","article-title":"Psoriasis severity: commonly used clinical thresholds may not adequately convey patient impact","volume":"35","author":"Golbari","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s13555-020-00455-y","article-title":"Dermoscopy in monitoring and predicting therapeutic response in general dermatology (non-tumoral dermatoses): an up-to-date overview","volume":"10","author":"Errichetti","year":"2020","journal-title":"Dermatol Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s13555-021-00486-z","article-title":"Treatment of mild-to-moderate plaque psoriasis with a new 650-microsecond 1064-Nm Nd:Yag laser: clinical and dermoscopic assessment","volume":"11","author":"Ko\u0142t-Kami\u0144ska","year":"2021","journal-title":"Dermatol Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/srt.12271","article-title":"Clinical, ultrasound, and videodermatoscopy monitoring of psoriatic patients following biological treatment","volume":"22","author":"Micali","year":"2016","journal-title":"Skin Res Technol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/srt.12942","article-title":"Ultra-high-frequency ultrasound monitoring of plaque psoriasis during ixekizumab treatment","volume":"27","author":"Dini","year":"2021","journal-title":"Skin Res Technol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jdv.15344","article-title":"Dermoscopic features of psoriasis of the skin, scalp and nails - a systematic review","volume":"33","author":"Goli\u0144ska","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5826\/dpc.0604a02","article-title":"Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents","volume":"6","author":"Lallas","year":"2016","journal-title":"Dermatol Pract Concept."},{"key":"B11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1055\/a-1161-8872","article-title":"European federation of societies for ultrasound in medicine and biology (Efsumb) position statement on dermatologic ultrasound","volume":"42","author":"Alfageme","year":"2021","journal-title":"Ultraschall Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.7863\/jum.2009.28.11.1569","article-title":"High-frequency sonography in the evaluation of psoriasis: nail and skin involvement","volume":"28","author":"Gutierrez","year":"2009","journal-title":"J Ultrasound Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000083509","article-title":"The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis","volume":"210","author":"Schmitt","year":"2005","journal-title":"Dermatology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/039463201302600425","article-title":"Combined clinical, capillaroscopic and ultrasound evaluation during treatment of plaque psoriasis with oral cyclosporine","volume":"26","author":"Musumeci","year":"2013","journal-title":"Int J Immunopathol Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/bjd.18125","article-title":"Standardization of dermoscopic terminology and basic dermoscopic parameters to evaluate in general dermatology (non-neoplastic dermatoses): an expert consensus on behalf of the international dermoscopy society","volume":"182","author":"Errichetti","year":"2020","journal-title":"Br J Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.3892\/etm.2019.8015","article-title":"Possible role of Bmp-4 in the hyper-pigmentation of psoriatic plaques after anti-Tnf-\u03b1 treatment","volume":"18","author":"Di Costanzo","year":"2019","journal-title":"Exp Ther Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"763","DOI":"10.36849\/JDD.2020.4887","article-title":"Post-inflammatory hyperpigmentation: a review of treatment strategies","volume":"19","author":"Shenoy","year":"2020","journal-title":"J Drugs Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/jdv.16559","article-title":"Non-invasive clinical and microscopic evaluation of the response to treatment with clobetasol cream vs. calcipotriol\/betamethasone dipropionate foam in mild to moderate plaque psoriasis: an investigator-initiated, phase IV, unicentric, open, randomized clinical trial","volume":"35","author":"Y\u00e9lamos","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.3892\/etm.2019.8140","article-title":"High-frequency ultrasonography of psoriatic skin: a non-invasive technique in the evaluation of the entire skin of patients with psoriasis: a pilot study","volume":"18","author":"\u015eomlea","year":"2019","journal-title":"Exp Ther Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/jdv.18123","article-title":"Epidermal thickness in healthy humans: a systematic review and meta-analysis","volume":"36","author":"Lintzeri","year":"2022","journal-title":"J Eur Acad Dermatol Venereol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1162873\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T07:36:04Z","timestamp":1687764964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1162873\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":21,"alternative-id":["10.3389\/fmed.2023.1162873"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1162873","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"article-number":"1162873"}}